HIV :: Merck’s Thai price cut must come without strings on generics, says AHF

AIDS Healthcare Foundation (AHF), the US? largest provider of HIV/AIDS healthcare, education and prevention and operator of free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, today praised Merck for its decision to offer to reduce the price of its antiretroviral drug, efavirenz (marketed outside the US under the brand name Strocrin), in Thailand, but chided the multinational drug company for making the price cut offer contingent upon the Government of Thailand revoking a compulsory license it had issued in November 2006 for the manufacture and/or importation of a generic version of the drug.

Diabetes :: Study shows Diachrome improves blood sugar control in people with type 2 diabetes

Nutrition 21, Inc. (NASDAQ: NXXI) announced new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome?, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).

Liver Cancer :: Nexavar extends survival by 44% in liver cancer patients

Bayer HealthCare, a subsidiary of Bayer AG (NYSE: BAY), and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced that Nexavar? (sorafenib) tablets significantly extended overall survival in patients with hepatocellular carcinoma (HCC), or primary liver cancer versus those taking placebo by 44%.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack